PURPOSE: Two percent glutaraldehyde on colonic mucosa may result in a
toxic colitis, and the clinical features may mimic those of colonic is
chemia. The study was performed to determine the radiologic appearance
of glutaraldehyde-induced toxic colitis. MATERIALS AND METHODS: A ret
rospective review was performed with the clinical and imaging findings
in four patients with glutaraldehyde-induced colitis seen during a 6-
year period. RESULTS: Patients developed a self-limited syndrome of cr
amps and abdominal pain, tenesmus, and rectal bleeding within 48 hours
of uncomplicated sigmoidoscopy or colonoscopy. Sample cultures exclud
ed enteric pathogens. Computed tomography (CT) demonstrated circumfere
ntial thickening of the colonic wall in a left-sided distribution in a
ll patients. Heterogeneous mural enhancement (target-sign appearance)
was noted in two patients. Follow-up CT studies confirmed resolution o
f mural wall thickening with conservative management. CONCLUSION: The
clinical and radiologic features of glutaraldehyde-induced toxic colit
is may mimic those of colonic ischemia. This complication should be su
spected in patients who develop hemorrhagic colitis immediately after
undergoing colonoscopy.